Moderately or late preterm babies have higher risks of brain development disorders

Publicly released:
International
Photo by Kelly Sikkema on Unsplash
Photo by Kelly Sikkema on Unsplash

Babies born moderately preterm (32-33 weeks) or late preterm (34-36 weeks) are more likely to be diagnosed with a range of brain development disorders into their teens, according to international research. The team looked at diagnoses of motor, cognitive, epileptic, hearing, and visual impairments up to the age of 16 from a group of over a million babies born in Sweden between 1998 and 2012. They say the rate of all impairments was higher among those born moderately or late preterm, with a five-fold increased risk of motor impairment and a nearly two-fold increased risk of epileptic impairment the highest relative risks. The researchers say that while the study is observational and can't show cause-and-effect, about 80% of preterm births are within the 32-36 week window, so it is important to be aware of what to look out for as preterm babies grow up.

Media release

From: The BMJ

The BMJ

Externally peer reviewed? Yes
Evidence type: Observational cohort study
Subjects: Children

Study sheds more light on long term developmental risks of preterm birth

Higher risks faced by these children and their families should not be underestimated, say researchers

Children born moderately (32-33 weeks) or late preterm (34-36 weeks) have higher long term risks of neurodevelopmental difficulties that can affect their behaviour and ability to learn, finds a study of over one million children published by The BMJ today.

As these children comprise about 80% of all preterm births, these risks should not be underestimated, say the researchers. The findings may also help professionals and families achieve a better risk assessment and follow-up of these children.

Previous research shows that children born early have higher risks of neurodevelopmental and behavioural disabilities in the first years of life and throughout childhood and adolescence compared with children born at term. Yet few population based studies have investigated the long term neurodevelopmental outcomes of these children compared with children born at term.

To fill this knowledge gap, researchers used Swedish national registry data to assess long term neurodevelopmental outcomes of children born at different gestational ages, particularly 32-33 weeks (moderately preterm) and 34-36 weeks (late preterm), compared with 39-40 weeks (full term).

Their findings are based on 1,281,690 singleton children without birth defects born in Sweden at 32 to 41 weeks between 1998 and 2012 and a sub-group of 349,108 full siblings to control for unmeasured shared genetic and environmental factors.

The main outcomes of interest were movement (motor), brain (cognitive), epileptic, hearing, and visual impairments, and a combination of any neurodevelopmental impairment, diagnosed up to age 16 years.

Potentially influential factors were taken into account including mother’s age, parity, country of birth, cohabiting status, body mass index during early pregnancy, smoking during pregnancy, diabetic and hypertensive diseases, calendar period of delivery, parents’ educational level and history of neurological and psychiatric disorders, and infant’s sex and birth weight for gestational age.

During an average follow-up period of 13 years, 75,311 infants (48 per 10,000 person years) had at least one diagnosis of any neurodevelopmental impairment.

Some 5,899 (4 per 10,000 person years) had motor impairment, 27,371 (17 per 10,000) cognitive impairment, 11,870 (7 per 10,000) epileptic impairment, 19,700 (12 per 10,000) visual impairment, and 20,393 (13 per 10,000) hearing impairment.

Overall, compared with children born full term, those born moderately or late preterm showed higher risks for any impairment (e.g., an additional 475 cases per 10,000 population by age 16 years for children born moderately preterm compared with those born full term).

The highest relative risk for children born moderately preterm compared with those born full term was for motor impairment (a nearly five-fold increased risk), followed by epileptic impairment (a nearly two-fold increased risk).

Risks for neurodevelopmental impairments appeared highest from 32 weeks, then gradually declined until 41 weeks, with higher risks also at early term (37-38 weeks) than at full term.

In the sibling comparison analysis, most associations remained stable except for gestational age and epileptic and hearing impairments, where no association was found.

This is an observational study, so can’t establish cause and the researchers acknowledge that they were unable to provide precise information for some outcomes, and that possible under-reporting or misclassification of the diagnoses might lead to an underestimation of the associations found.

What’s more, they can’t rule out the possibility that other unmeasured factors, such as alcohol and substance misuse during pregnancy, may have influenced the results.

However, this was a large, population based study using high quality comprehensive national registries, making it possible to investigate clinically relevant risks across the spectrum of gestational age.

As such, they say: “Children born moderately or late preterm have higher risks of adverse neurodevelopmental outcomes. The risks should not be underestimated as these children comprise the largest proportion of children born preterm.”

“The findings may help professionals and families to better assess risk, follow-up, and healthcare systems planning for children born moderately or late preterm,” they add.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research The BMJ, Web page The URL will go live after the embargo ends
Journal/
conference:
The BMJ
Research:Paper
Organisation/s: Karolinska Institutet, Sweden
Funder: AM was supported by Karolinska Institutet Research Foundation grants. RC was supported by the 100 Talents Plan Foundation of Sun Yat-sen University. JB was supported by Region Stockholm (clinical postdoctoral appointment) and Karolinska Institutet Research Foundation grants. This study was funded by the Swedish Research Council (No 4-2979/2020). OS was supported by the Swedish Research Council (2013-09298) and the Strategic Research Program in Epidemiology at Karolinska Institutet. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.
Media Contact/s
Contact details are only visible to registered journalists.